EUVIMEDEUVIMED entdecken
Open Access

Spatiotemporal Role of GLI2 in Driving SHH-Medulloblastoma Tumorigenesis

Najiba Murad iD, Zhenhua Xu, Jiao Zhang, Xiao Liu, Prathibhani Ramawickrama, Ran Tao, Samuel Rivero-Hinojosa, Melanie Schoof iD, Ulrich Schüller iD, Qingshi Chen, Brian R Rood, Roger Packer und 7 weitere

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noag033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Najiba Murad und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer and Immunology, Brain Tumor Institute, Children's National Hospital, Washington. Hauptthemen laut MEDLINE: Zinc Finger Protein Gli2, Medulloblastoma, Hedgehog Proteins, Cerebellar Neoplasms. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, German Cancer Aid, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medulloblastoma (MB) is a malignant cerebellar tumor primarily affecting children. SHH MB with GLI2 amplification is associated with a particularly poor prognosis. Although GLI2 amplification is clinically recognized, its role in driving SHH-MB remains unclear.

Methods

We generated novel mouse models of GLI2-amplified MB to investigate the role of GLI2 in driving tumorigenesis and assessed their similarity to human tumors using immunohistological and scRNA-seq analyses. Additionally, we examined the spatiotemporal window of tumor development using our mouse models and explored the mechanisms underlying the susceptibility of embryonic cerebellar granule cell progenitors (GCPs) to GLI2-induced tumorigenesis through scRNA-seq analysis. We further investigated the involvement of MAPK pathway in GLI2-driven tumorigenesis and progression by genetically disrupting the pathway.

Results

We demonstrate that GLI2 is a primary oncogenic driver in SHH-MB, with its overexpression driving embryonic Math1+ progenitor cells to form SHH-MB. The resulting GLI2-driven tumors closely resemble human GLI2-amplified SHH-MB cellularly and molecularly. Additionally, we determined that embryonic Math1+ GCPs at E13.5–E15.5 are the most susceptible to tumor initiation with GLI2 overexpression alone. In postnatal Math1+ GCPs, additional Trp53 inactivation is required for GLI2-induced tumor formation. scRNA-seq analysis reveals MAPK pathway enrichment in embryonic GCPs and GLI2-driven tumors. Functional studies show that knocking down MEK1/2 in Math1+ progenitor cells or GLI2-driven MB cells prevents tumorigenesis and tumor progression, respectively.

Conclusions

Our studies uncover the developmental origins and molecular mechanisms underlying GLI2-amplified SHH-MB. We also reveal that the MAPK pathway plays a critical role in GLI2-driven SHH-MB tumorigenesis and progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc Finger Protein Gli2MedulloblastomaHedgehog ProteinsCerebellar NeoplasmsCarcinogenesisAnimalsMiceHumans

Stichwörter der Autor:innen

GLI2-amplificationMAPK signaling pathwayMedulloblastomacell-of-origintumor development window

Substanzen

Zinc Finger Protein Gli2Hedgehog ProteinsGli2 protein, mouse

Autor:innen und Institutionen

  • Center for Cancer and Immunology, Brain Tumor Institute, Children's National Hospital, Washington.
  • Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston.
  • Department of Pediatrics-Hematology/Oncology and Neurosurgery, Baylor College of Medicine, Houston.
  • Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis.
  • Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Research Institute Children's Cancer Center, Hamburg, Germany.

ORCID-Profile: Najiba Murad, Melanie Schoof, Ulrich Schüller, Yanxin Pei

Förderung

  • NINDS NIH HHS
  • German Cancer Aid
  • NIH HHS
  • NCI NIH HHS
  • NIAMS NIH HHS
  • Fördergemeinschaft Kinderkrebszentrum Hamburg

Zitieren

APA

Murad, N., Xu, Z., Zhang, J., Liu, X., Ramawickrama, P., Tao, R., Rivero-Hinojosa, S., Schoof, M., Schüller, U., Chen, Q., Rood, B. R., Packer, R., Nair, L. R., Grachtchouk, M., Dlugosz, A., Yang, J., Taylor, M. D., Pei, H., & Pei, Y. (2026). Spatiotemporal Role of GLI2 in Driving SHH-Medulloblastoma Tumorigenesis. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag033

Vancouver

Murad N, Xu Z, Zhang J, Liu X, Ramawickrama P, Tao R, et al. Spatiotemporal Role of GLI2 in Driving SHH-Medulloblastoma Tumorigenesis. Neuro-Oncology. 2026. doi:10.1093/neuonc/noag033

BibTeX
@article{Murad2026,
  author = {Murad, Najiba and Xu, Zhenhua and Zhang, Jiao and Liu, Xiao and Ramawickrama, Prathibhani and Tao, Ran and Rivero-Hinojosa, Samuel and Schoof, Melanie and Schüller, Ulrich and Chen, Qingshi and Rood, Brian R and Packer, Roger and Nair, Lakshmi Ramachandran and Grachtchouk, Marina and Dlugosz, Andrzej and Yang, Jianhua and Taylor, Michael D and Pei, Huadong and Pei, Yanxin},
  title = {Spatiotemporal Role of GLI2 in Driving SHH-Medulloblastoma Tumorigenesis},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noag033}
}
Kostenlos starten →